Mesoblast
MESO
43 hedge funds and large institutions have $7M invested in Mesoblast in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 7 closing their positions.
321% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $454K
157% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 7
0.58% less ownership
Funds ownership: 1.68% → 1.1% (-0.58%)
2% less funds holding
Funds holding: 44 → 43 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
50% less capital inflows, than outflows
Capital inflows: $1.95M | Capital outflows: $3.92M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$391K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$354K |
| 3 |
BlackRock
New York
|
+$205K |
| 4 |
Morgan Stanley
New York
|
+$124K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M&G Investment Management
London,
United Kingdom
|
-$1.74M |
| 2 |
State Street
Boston,
Massachusetts
|
-$757K |
| 3 |
Millennium Management
New York
|
-$753K |
| 4 |
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
-$556K |
| 5 |
DTL
Dynamic Technology Lab
Singapore
|
-$56K |
MESO Hedge Fund Activity: Q2 2023 in Review
43 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2023, worth a combined $7M — down 12% from $7.97M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MESO and 6 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 18 added.
The largest buyer was Jane Street, opening a new position worth an estimated $391K. The largest seller was M&G Investment Management, exiting entirely with an estimated $1.74M sold.
- 43 institutional investors held Mesoblast (MESO) as of Q2 2023, down from 44 in Q1 2023.
- Funds reported $7M of Mesoblast stock for Q2 2023, down 12% quarter-over-quarter.
- 6 funds opened new Mesoblast positions in Q2 2023 and 7 closed out, a net change of -1 holder.
- The largest Mesoblast buyer in Q2 2023 was Jane Street, an estimated $391K added.
- The largest Mesoblast seller in Q2 2023 was M&G Investment Management, an estimated $1.74M sold.
Based on aggregated 13F filings for Q2 2023.